Notably, O-GlcNAcylation of ankyrin-G was significantly down-regulated at multiple modification sites in the post-mortem human brain tissues with Alzheimer’s disease (AD)61, implying a potential contribution of dysregulated localization of ankyrin-G to the etiology of AD. Here, ANK3 is linked to Alzheimer disease.